IBDEI1YM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31309,1,3,0)
 ;;=3^Diseases of the circ sys comp pregnancy, first trimester
 ;;^UTILITY(U,$J,358.3,31309,1,4,0)
 ;;=4^O99.411
 ;;^UTILITY(U,$J,358.3,31309,2)
 ;;=^5017970
 ;;^UTILITY(U,$J,358.3,31310,0)
 ;;=O99.412^^126^1623^9
 ;;^UTILITY(U,$J,358.3,31310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31310,1,3,0)
 ;;=3^Diseases of the circ sys comp pregnancy, second trimester
 ;;^UTILITY(U,$J,358.3,31310,1,4,0)
 ;;=4^O99.412
 ;;^UTILITY(U,$J,358.3,31310,2)
 ;;=^5017971
 ;;^UTILITY(U,$J,358.3,31311,0)
 ;;=O99.413^^126^1623^10
 ;;^UTILITY(U,$J,358.3,31311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31311,1,3,0)
 ;;=3^Diseases of the circ sys comp pregnancy, third trimester
 ;;^UTILITY(U,$J,358.3,31311,1,4,0)
 ;;=4^O99.413
 ;;^UTILITY(U,$J,358.3,31311,2)
 ;;=^5017972
 ;;^UTILITY(U,$J,358.3,31312,0)
 ;;=O99.43^^126^1623^11
 ;;^UTILITY(U,$J,358.3,31312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31312,1,3,0)
 ;;=3^Diseases of the circ sys complicating the puerperium
 ;;^UTILITY(U,$J,358.3,31312,1,4,0)
 ;;=4^O99.43
 ;;^UTILITY(U,$J,358.3,31312,2)
 ;;=^5017975
 ;;^UTILITY(U,$J,358.3,31313,0)
 ;;=O33.0^^126^1623^44
 ;;^UTILITY(U,$J,358.3,31313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31313,1,3,0)
 ;;=3^Matern care for disproprtn d/t deformity of matern pelv bone
 ;;^UTILITY(U,$J,358.3,31313,1,4,0)
 ;;=4^O33.0
 ;;^UTILITY(U,$J,358.3,31313,2)
 ;;=^5016691
 ;;^UTILITY(U,$J,358.3,31314,0)
 ;;=O99.810^^126^1623^1
 ;;^UTILITY(U,$J,358.3,31314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31314,1,3,0)
 ;;=3^Abnormal glucose complicating pregnancy
 ;;^UTILITY(U,$J,358.3,31314,1,4,0)
 ;;=4^O99.810
 ;;^UTILITY(U,$J,358.3,31314,2)
 ;;=^5017994
 ;;^UTILITY(U,$J,358.3,31315,0)
 ;;=O99.815^^126^1623^2
 ;;^UTILITY(U,$J,358.3,31315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31315,1,3,0)
 ;;=3^Abnormal glucose complicating the puerperium
 ;;^UTILITY(U,$J,358.3,31315,1,4,0)
 ;;=4^O99.815
 ;;^UTILITY(U,$J,358.3,31315,2)
 ;;=^5017996
 ;;^UTILITY(U,$J,358.3,31316,0)
 ;;=O24.410^^126^1623^24
 ;;^UTILITY(U,$J,358.3,31316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31316,1,3,0)
 ;;=3^Gestational DM in Pregnancy,Diet Controlled
 ;;^UTILITY(U,$J,358.3,31316,1,4,0)
 ;;=4^O24.410
 ;;^UTILITY(U,$J,358.3,31316,2)
 ;;=^5016272
 ;;^UTILITY(U,$J,358.3,31317,0)
 ;;=O24.414^^126^1623^25
 ;;^UTILITY(U,$J,358.3,31317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31317,1,3,0)
 ;;=3^Gestational DM in Pregnancy,Insulin Controlled
 ;;^UTILITY(U,$J,358.3,31317,1,4,0)
 ;;=4^O24.414
 ;;^UTILITY(U,$J,358.3,31317,2)
 ;;=^5016273
 ;;^UTILITY(U,$J,358.3,31318,0)
 ;;=O24.415^^126^1623^23
 ;;^UTILITY(U,$J,358.3,31318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31318,1,3,0)
 ;;=3^Gestational DM in Pregnancy,Ctrl by Oral Hypoglycemic Drugs
 ;;^UTILITY(U,$J,358.3,31318,1,4,0)
 ;;=4^O24.415
 ;;^UTILITY(U,$J,358.3,31318,2)
 ;;=^5139041
 ;;^UTILITY(U,$J,358.3,31319,0)
 ;;=O24.430^^126^1623^27
 ;;^UTILITY(U,$J,358.3,31319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31319,1,3,0)
 ;;=3^Gestational DM in Puerperium,Diet Controlled
 ;;^UTILITY(U,$J,358.3,31319,1,4,0)
 ;;=4^O24.430
 ;;^UTILITY(U,$J,358.3,31319,2)
 ;;=^5016278
 ;;^UTILITY(U,$J,358.3,31320,0)
 ;;=O24.434^^126^1623^28
 ;;^UTILITY(U,$J,358.3,31320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31320,1,3,0)
 ;;=3^Gestational DM in Puerperium,Insulin Controlled
 ;;^UTILITY(U,$J,358.3,31320,1,4,0)
 ;;=4^O24.434
